Citable filing context
CI's research view summarizes recent SEC filing context, starting with earnings from Jul 30, 2026.
| Filed | Item | Context |
|---|---|---|
| Jul 30, 2026 | earnings | The Cigna Group reported Q2 2026 revenue of $71.7 billion and adjusted income of $2.1 billion. |
| May 13, 2026 | guidance_update | The Cigna Group reaffirmed its full year 2026 projected adjusted income from operations of at least $30.35 per share. |
| Apr 30, 2026 | earnings | The Cigna Group reported Q1 2026 revenues of $68.5 billion and raised its 2026 adjusted income outlook. |
| Jul 30, 2026 | Guidance: adjusted_income_from_operations_per_share | 30.45 to not reported |
| Jul 30, 2026 | Guidance: cigna_healthcare_adjusted_income_from_operations_pre_tax | 4550.00 to not reported |
| Jul 30, 2026 | Guidance: cigna_healthcare_medical_care_ratio | 83.70 to 84.70 |
| Jul 30, 2026 | mda_quarterly | The Cigna Group’s financial performance for the first half of 2026 reflects growth in its core Evernorth Health Services and Cigna Healthcare segments, despite the impact of the March 2025 divestiture of its Medicare Advantage and related businesses. Shareholders' net income rose 16% to $3.31 billion for the six months ended June 30, 2026, compared to the same period in 2025. Evernorth Health Services remains a primary revenue driver, with adjusted revenues increasing 8% to $119.91 billion, fueled by claims composition and customer growth in Specialty and Care Services. However, pre-tax adjusted income for this segment remained flat as client-focused initiatives and lower pharmacy claim volumes offset operational efficiencies. Cigna Healthcare saw a 17% increase in pre-tax adjusted income, driven by improved margins in the U.S. Employer business and premium rate increases, despite the revenue decline associated with the HCSC divestiture. The company is executing a multi-year "Strategic Optimization Program" to improve operational efficiency, incurring $450 million in pre-tax costs during the first half of 2026, primarily for severance. Liquidity remains supported by $6.6 billion in cash and short-term investments and $6.5 billion in undrawn revolving credit capacity. Key risks include medical cost inflation, regulatory changes, and potential volatility in the investment portfolio. |
| Apr 30, 2026 | mda_quarterly | Shareholders' net income rose 25% to $1.65 billion in the first quarter of 2026, with adjusted income from operations increasing 12% to $2.06 billion. Evernorth Health Services reported a 9% increase in adjusted revenues to $58.4 billion, driven by pharmacy claims composition and customer growth in Specialty and Care Services. Cigna Healthcare adjusted revenues declined 21% to $11.5 billion, primarily due to the divestiture of Medicare Advantage and related businesses via the HCSC transaction. Despite this, the segment's pre-tax adjusted income grew 18% to $1.51 billion, supported by improved margins in U.S. Employer and Individual and Family Plans and a 240-basis point decrease in the medical care ratio to 79.8%. The company is executing a Strategic Optimization Program through 2028, incurring $380 million in pre-tax costs this quarter, largely from severance. Key financial risks include the Inflation Reduction Act's negative impact on operating cash flows and a 25% exposure to the office sector within its $1.3 billion commercial mortgage loan portfolio. The debt-to-capitalization ratio stood at 42.3%, and the company paused share repurchases during the period. |
Source: SEC EDGAR filing text and events; period Jul 30, 2026; filed Jul 30, 2026.
CI company research is available with Aerarium Pro (CAD $10/mo). The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay free. Already a subscriber? Sign in to pick up where you left off.